Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$360K Buy
1,025
+272
+36% +$97K 0.03% 419
2025
Q4
$246K Buy
753
+31
+4% +$9.83K 0.02% 446
2025
Q3
$204K Buy
722
+1
+0.1% +$290 0.02% 492
2025
Q2
$201K Buy
+721
New +$204K 0.02% 462
2024
Q4
Sell
-633
Closed -$204K 418
2024
Q3
$204K Buy
+633
New +$207K 0.02% 384

Other funds holding AMGN

Inspire Advisors's AMGN Position: Q1 2026 in Review

Inspire Advisors increased its Amgen (AMGN) stake by 36% in Q1 2026, buying an estimated $97K and bringing the position to 1,025 shares worth $360K. The position accounts for 0.03% of the portfolio, ranked #419.

Inspire Advisors first reported a position in AMGN in Q3 2024 and has held it in 5 quarters since. 3,129 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Inspire Advisors held 1,025 shares of Amgen worth $360K as of Q1 2026.
  • Inspire Advisors bought 272 Amgen shares in Q1 2026, an estimated $97K.
  • Amgen made up 0.03% of Inspire Advisors's portfolio in Q1 2026, its #419 holding.
  • Inspire Advisors first reported a position in Amgen in Q3 2024 and has held it in 5 quarters since.
  • 3,129 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Inspire Advisors's 13F filing for Q1 2026, filed 15 May 2026.